Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Chiltern opens St Petersburg office to service growth

Chiltern International : 14 April, 2008  (Company News)
Chiltern has opened a new office in St Petersburg, Russia following the recent appointment of Dr Alexey Kornilov as general manager of its Russian operations.
The St Petersburg office is expected to grow rapidly under the leadership of Kornilov and will be primarily focused on supporting Chiltern’s Global Clinical Development brand. Dr Kornilov brings over 10 years of clinical experience to Chiltern and is a member of the St Petersburg Society of Anaesthesiology.

Over the last few years, Chiltern has conducted many trials in Russia to fulfill sponsors' demands in the region and to take advantage of highly qualified investigator sites generating high quality data.

'The opening of our St Petersburg office is a logical next step in Chiltern's continued growth in Central and Eastern Europe,' commented Armand Czaplinski MD, MBA, Chiltern general manager, CEE. 'Today, with an ever higher number of competing trials, the pharmaceutical industry increasingly recognises the potential of CEE countries to meet enrollment goals. The availability of trained staff and the quality of the data produced, has resulted in an increased number of FDA and EMEA approved clinical trials.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo